NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 308 filers reported holding NATERA INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,261,609 | -29.9% | 367,494 | -22.9% | 0.34% | -26.3% |
| Q2 2023 | $23,204,202 | -38.5% | 476,864 | -29.9% | 0.46% | -39.4% |
| Q1 2023 | $37,757,764 | +24.3% | 680,075 | -10.0% | 0.75% | +22.4% |
| Q4 2022 | $30,368,520 | -1.1% | 756,000 | +7.8% | 0.62% | -6.7% |
| Q3 2022 | $30,718,000 | +20.0% | 701,000 | -3.0% | 0.66% | +28.7% |
| Q2 2022 | $25,606,000 | -12.9% | 722,525 | +0.0% | 0.51% | +5.6% |
| Q1 2022 | $29,387,000 | +8.7% | 722,400 | +149.5% | 0.48% | +20.3% |
| Q4 2021 | $27,036,000 | -16.2% | 289,495 | 0.0% | 0.40% | -18.6% |
| Q3 2021 | $32,261,000 | -43.4% | 289,495 | -42.3% | 0.50% | -42.2% |
| Q2 2021 | $56,988,000 | +11.8% | 501,965 | 0.0% | 0.86% | +4.9% |
| Q1 2021 | $50,970,000 | -24.2% | 501,965 | -25.8% | 0.82% | -28.3% |
| Q4 2020 | $67,287,000 | +25.0% | 676,115 | -9.2% | 1.14% | +8.2% |
| Q3 2020 | $53,810,000 | +66.7% | 744,876 | +15.1% | 1.05% | +61.9% |
| Q2 2020 | $32,272,000 | +197.2% | 647,248 | +78.0% | 0.65% | +152.3% |
| Q1 2020 | $10,860,000 | -18.3% | 363,711 | -7.9% | 0.26% | +9.8% |
| Q4 2019 | $13,300,000 | -1.7% | 394,771 | -4.3% | 0.24% | -4.5% |
| Q3 2019 | $13,535,000 | -3.8% | 412,649 | -19.1% | 0.25% | -0.8% |
| Q2 2019 | $14,076,000 | +33.0% | 510,386 | -0.5% | 0.25% | +30.5% |
| Q1 2019 | $10,581,000 | +142.5% | 513,141 | +64.2% | 0.19% | +118.4% |
| Q4 2018 | $4,364,000 | -58.0% | 312,591 | -28.0% | 0.09% | -47.3% |
| Q3 2018 | $10,392,000 | +2.9% | 434,091 | -19.1% | 0.16% | -2.4% |
| Q2 2018 | $10,104,000 | +86.2% | 536,866 | -8.3% | 0.17% | +81.7% |
| Q1 2018 | $5,427,000 | +18.6% | 585,426 | +15.0% | 0.09% | +19.2% |
| Q4 2017 | $4,575,000 | -30.2% | 508,881 | 0.0% | 0.08% | -31.6% |
| Q3 2017 | $6,559,000 | +38.4% | 508,881 | +16.6% | 0.11% | +37.3% |
| Q2 2017 | $4,738,000 | +49.7% | 436,290 | +22.2% | 0.08% | +48.2% |
| Q1 2017 | $3,166,000 | +26.7% | 356,965 | +67.3% | 0.06% | +19.1% |
| Q4 2016 | $2,499,000 | -49.6% | 213,380 | -53.3% | 0.05% | -40.5% |
| Q3 2015 | $4,955,000 | – | 456,657 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |